Skip to main content
Fig. 1 | Allergy, Asthma & Clinical Immunology

Fig. 1

From: Protective barrier properties of Rhinosectan® spray (containing xyloglucan) on an organotypic 3D airway tissue model (MucilAir): results of an in vitro study

Fig. 1

Preservation of paracellular flux by Rhinosectan® between the apical and basolateral compartments of MucilAir. a LY permeability after 15 min and 1 h (plus 1 h of recovery) (LY flux (%) values). b LY permeability after 2 h of pre-treatment and 16 h of exposure to pro-inflammatory compounds (LY flux (%) values)

Back to article page